167 related articles for article (PubMed ID: 1425310)
21. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
[TBL] [Abstract][Full Text] [Related]
22. Organ-sparing treatment of bladder cancer: an innovative approach.
Kaufman DS; Shipley WU
Am Fam Physician; 1997 Mar; 55(4):1257-62. PubMed ID: 9092286
[TBL] [Abstract][Full Text] [Related]
23. Treatment of high-risk, non-muscle-invasive bladder cancer.
Lerner SP
Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
[No Abstract] [Full Text] [Related]
24. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.
Stein JP; Skinner DG
BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375
[No Abstract] [Full Text] [Related]
25. Selection of treatment for muscle infiltrating transitional cell bladder cancer.
Whitmore WF
Arch Esp Urol; 1990; 43 Suppl 2():219-22. PubMed ID: 2096783
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of pre- and postoperative cisplatin, methotrexate and vinblastine in infiltrating bladder cancer: a three year experience.
Droz JP; Azab MB; Theodore C; Ghosn M; Ostronoff M; Boutan-Laroze A; Court BH; Perrin JL; Travagli JP; Wibault P
Prog Clin Biol Res; 1990; 353():137-42. PubMed ID: 2217411
[No Abstract] [Full Text] [Related]
27. Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.
Tsai HK; Katz MS; Coen JJ; Zietman AL; Kaufman DS; Shipley WU
Urology; 2006 Dec; 68(6):1188-92. PubMed ID: 17141846
[TBL] [Abstract][Full Text] [Related]
28. [Guideline on urothelial carcinoma of the bladder].
Bevers RF; Battermann JJ; Gietema JA; Hulsbergen-Van de Kaa CA; de Reijke TM; Feller N; Witjes JA; ;
Ned Tijdschr Geneeskd; 2009; 153():A956. PubMed ID: 20051162
[TBL] [Abstract][Full Text] [Related]
29. Combining surgery and chemotherapy for invasive bladder cancer: current and future directions.
Amiel GE; Lerner SP
Expert Rev Anticancer Ther; 2006 Feb; 6(2):281-91. PubMed ID: 16445380
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
[No Abstract] [Full Text] [Related]
31. [Organ-preserving therapy of invasive bladder carcinoma].
Sauer R; Dunst J
Dtsch Med Wochenschr; 1993 Feb; 118(6):205. PubMed ID: 8436074
[No Abstract] [Full Text] [Related]
32. [Organ-preserving therapy in invasive bladder carcinoma].
Dunst J; Bornhof C; Altendorf-Hofmann A; Wittekind C; Schrott KM; Sauer R
Dtsch Med Wochenschr; 1992 Nov; 117(47):1783-8. PubMed ID: 1425303
[TBL] [Abstract][Full Text] [Related]
33. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
[TBL] [Abstract][Full Text] [Related]
34. Alternatives to cystectomy in muscle-invasive bladder cancer.
Goel S
J Clin Oncol; 2003 Aug; 21(15):3003; author reply 3003-4. PubMed ID: 12885826
[No Abstract] [Full Text] [Related]
35. Organ preservation for muscle-invasive bladder cancer by transurethral resection.
Leibovici D; Kassouf W; Pisters LL; Pettaway CA; Wu X; Dinney CP; Grossman HB
Urology; 2007 Sep; 70(3):473-6. PubMed ID: 17905099
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
Simon SD; Srougi M
Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
[No Abstract] [Full Text] [Related]
37. Defining optimal therapy for muscle invasive bladder cancer.
Herr HW; Dotan Z; Donat SM; Bajorin DF
J Urol; 2007 Feb; 177(2):437-43. PubMed ID: 17222605
[TBL] [Abstract][Full Text] [Related]
38. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
Escudero Barrilero A
Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
[No Abstract] [Full Text] [Related]
39. Upfront chemotherapy in invasive bladder cancer.
Splinter TA; Kok TC
Prog Clin Biol Res; 1992; 378():111-6. PubMed ID: 1301571
[No Abstract] [Full Text] [Related]
40. [Comparative evaluation of effectiveness of some methods of treatment in locally invasive cancer of the urinary bladder].
Nechiporenko NA; Bushma TV
Vopr Onkol; 1993; 39(7-12):307-12. PubMed ID: 7825304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
